Skip to main content

Table 5 Results of Meta-analysis of hospitalization days

From: Clinical and economic outcomes of hospital pharmaceutical care: a systematic review and meta-analysis

Study | SMD [95% Conf. Interval] % Weight
Shen (2011) [18] | -1.600 −2.871 −0.329 60.15
Cies (2013) [21] | -3.000 −6.131 0.131 9.92
Dager (2014) | -2.700 −4.502 −0.898 29.93
I-V pooled WMD | -2.068 −3.054 −1.082 100.00
  1. Heterogeneity chi-squared = 1.33 (d.f. = 2) p = 0.513.
  2. I-squared (variation in WMD attributable to heterogeneity) = 0.0%.
  3. Test of WMD = 0: z = 4.11 p = 0.000.
  4. The significance level of the combined effect quantity test: 0.05.
  5. The significance level of the heterogeneity test: 0.1.
  6. Heterogeneity test: p > 0.1, no heterogeneity was considered; p < 0.1, heterogeneity was considered.